Intact Investment Management Inc. acquired a new position in Mettler-Toledo International Inc. (NYSE:MTD – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 100 shares of the medical instruments supplier’s stock, valued at approximately $122,000.
Other hedge funds also recently modified their holdings of the company. SBI Securities Co. Ltd. bought a new stake in shares of Mettler-Toledo International in the 4th quarter worth approximately $33,000. Blue Trust Inc. lifted its position in shares of Mettler-Toledo International by 70.8% during the 4th quarter. Blue Trust Inc. now owns 41 shares of the medical instruments supplier’s stock worth $50,000 after buying an additional 17 shares during the period. Whipplewood Advisors LLC bought a new position in shares of Mettler-Toledo International during the 4th quarter worth approximately $54,000. Sound Income Strategies LLC lifted its position in shares of Mettler-Toledo International by 4,500.0% during the 4th quarter. Sound Income Strategies LLC now owns 46 shares of the medical instruments supplier’s stock worth $56,000 after buying an additional 45 shares during the period. Finally, Farther Finance Advisors LLC lifted its position in shares of Mettler-Toledo International by 14.3% during the 4th quarter. Farther Finance Advisors LLC now owns 64 shares of the medical instruments supplier’s stock worth $78,000 after buying an additional 8 shares during the period. Institutional investors own 95.07% of the company’s stock.
Insider Activity
In other Mettler-Toledo International news, insider Gerry Keller sold 600 shares of the business’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total value of $810,804.00. Following the completion of the transaction, the insider now directly owns 6 shares of the company’s stock, valued at approximately $8,108.04. The trade was a 99.01 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Christian Magloth sold 790 shares of the business’s stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the completion of the transaction, the insider now directly owns 734 shares of the company’s stock, valued at approximately $964,248.46. The trade was a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.94% of the company’s stock.
Mettler-Toledo International Stock Performance
Mettler-Toledo International (NYSE:MTD – Get Free Report) last released its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 EPS for the quarter, beating the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. Equities research analysts forecast that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Several equities analysts recently commented on the company. Robert W. Baird raised their target price on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Wells Fargo & Company raised their target price on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the stock an “equal weight” rating in a research report on Monday, February 10th. Citigroup cut their target price on Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating for the company in a research report on Tuesday, March 4th. Wolfe Research initiated coverage on Mettler-Toledo International in a research report on Friday, December 13th. They issued a “peer perform” rating for the company. Finally, Evercore ISI lifted their price objective on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a research report on Monday, February 10th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $1,380.50.
View Our Latest Research Report on MTD
Mettler-Toledo International Profile
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
See Also
- Five stocks we like better than Mettler-Toledo International
- Consumer Discretionary Stocks Explained
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- What is Put Option Volume?
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International Inc. (NYSE:MTD – Free Report).
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.